Frontiers in Medical Technology, 2022 · DOI: 10.3389/fmedt.2022.693438 · Published: February 22, 2022
Spinal cord injury (SCI) often results in significant neurological dysfunction and long-term disability. Globally, the prevalence of SCI is estimated between 40 to 80 cases per million population per year. Stem cells are defined as immature cells that have the capacity to self-renew and to develop into specialized cells, that is, they can become any cell type present within an organism. Electroactive scaffolds bear the advantage of enhancing the complex electrical transmission function of neuronal networks during cell-to-substrate and cell-to-cell interactions.
Electroactive scaffolds offer promise in reconstituting the architecture of the damaged spinal cord and promoting regeneration.
There is clear potential for electroactive scaffolds to modulate NSC behavior post-transplantation and enhance their regenerative capability.
New technologies in degradable electroactive hydrogels may make translation of implantable electroactive biomaterials for NSC therapy more realistic.